About 5,540,000 results
Open links in new tab
Bristol Myers-2seventy Bio Halt Phase 3 Trial For Abecma In …
Struggling 2Seventy scraps a key cancer study - BioPharma Dive
2seventy, Bristol Myers Drop Abecma Study in Newly
BMS, 2seventy scrap Abecma trial in first-line multiple myeloma
2seventy bio Provides Update on KarMMa-9 Study and Previews …
2seventy bio Provides Update on KarMMa-9 Study and Previews …
2seventy bio Announces Completion of Oncology and …
2seventy bio Announces Strategic Restructuring to Prioritize …
2seventy bio Announces New Strategic Path Forward
2seventy, Bristol Myers Discontinue Enrollment In Phase 3